CARL ZEISS MEDITEC revenue for the last year amounted to 2.07 B EUR, the most of which — 1.59 B EUR — came from its highest performing source at the moment, Ophthalmology, the year earlier bringing 1.58 B EUR. The greatest contribution to the revenue figure was made by Asia Pacific — last year it brought CARL ZEISS MEDITEC 948.35 M EUR, and the year before that — 1.00 B EUR.